Evidence map›Paper›PMID 39266897›Full record

ArticleNeurochemical research2024

Neuromedin U Neurons in the Edinger-Westphal Nucleus Respond to Alcohol Without Interfering with the Urocortin 1 Response.

Mireia Medrano, Wissal Allaoui, Ra'fat Ehab Salim Haddad, Leila Makrini-Maleville, Emmanuel Valjent, Ilse Smolders, Viktória Kormos, Balázs Gaszner, Dimitri De Bundel

Abstract read
In one paragraph

Article in Neurochemical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mireia MedranoCenter for Neurosciences, Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information, Research Group Experimental Pharmacology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium.
Wissal AllaouiCenter for Neurosciences, Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information, Research Group Experimental Pharmacology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium.
Ra'fat Ehab Salim HaddadMedical School, Research Group for Mood Disorders, Department of Anatomy and Centre for Neuroscience, University of Pécs, Szigeti út 12, 7624, Pécs, Hungary.
Leila Makrini-MalevilleIGF, Université de Montpellier, CNRS, Inserm, Montpellier, France.
Emmanuel ValjentIGF, Université de Montpellier, CNRS, Inserm, Montpellier, France.
Ilse SmoldersCenter for Neurosciences, Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information, Research Group Experimental Pharmacology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium.
Viktória KormosMedical School, Department of Pharmacology and Pharmacotherapy, University of Pécs, Szigeti út 12, 7624, Pécs, Hungary.
Balázs Gaszner *Medical School, Research Group for Mood Disorders, Department of Anatomy and Centre for Neuroscience, University of Pécs, Szigeti út 12, 7624, Pécs, Hungary. balazs.b.gaszner@aok.pte.hu.
Dimitri De Bundel *Center for Neurosciences, Department of Pharmaceutical Chemistry, Drug Analysis and Drug Information, Research Group Experimental Pharmacology, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090, Brussels, Belgium. dimitri.de.bundel@vub.be.

Funding

Agence Nationale de la Recherche Bergmann & Co, ANR-20-CE37-0024Általános Orvostudományi Kar, Pécsi Tudományegyetem KA-2022-29Fund for Scientific Research Flanders FWO G028716NInserm, Fondation pour la Recherche Médicale EQU202203014705National Research, Development and Innovation Fund of Hungary TKP2021-EGA-16Nemzeti Kutatási Fejlesztési és Innovációs Hivatal NKFIH K-146117New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund ÚNKP-23-5-PTE-1991the János Bolyai Research Scholarship of the Hungarian Academy of Sciences BO/00750/22/5Vrije Universiteit Brussel SRP49
6 · The paper itself

Abstract

The Edinger-Westphal nucleus (EW) is a midbrain nucleus composed of a preganglionic, cholinergic subpopulation and a densely clustered peptidergic subpopulation (EWcp). The EWcp is one of the few brain regions that show consistent induction of FOS following voluntary alcohol intake. Previous results in rodents point to urocortin 1 (UCN1) as one of the peptides most involved in the control of ethanol intake and preference. Notably, the functions described for UCN1, such as reward processing, stress coping or the regulation of feeding behavior are similar to those described for the neuropeptide neuromedin U (NMU). Interestingly, NMU has been recently associated with the modulation of alcohol-related behaviors. However, little is known about the expression and functionality of NMU neurons in alcohol-responsive areas. In this study, we used the recently developed Nmu-Cre knock-in mouse model to examine the expression of NMU in the subaqueductal paramedian zone comprising the EWcp. We delved into the characterization and co-expression of NMU with other markers already described in the EWcp. Moreover, using FOS as a marker of neuronal activity, we tested whether NMU neurons were sensitive to acute alcohol administration. Overall, we provided novel insights on NMU expression and functionality in the EW region. We showed the presence of NMU within a subpopulation of UCN1 neurons in the EWcp and demonstrated that this partial co-expression does not interfere with the responsivity of UCN1-containing cells to alcohol. Moreover, we proposed that the UCN1 content in these neurons may be influenced by sex.

Indexed as

Edinger-Westphal NucleusEthanolNeuronsNeuropeptidesUrocortinsAlcohol DrinkingAnimalsFemaleMaleMiceMice, Inbred C57BLMice, TransgenicEthanolneuromedin UNeuropeptidesUcn1 protein, mouseUrocortinsAlcoholEdinger–Westphal nucleusKnock-in mouse modelNeuromedin UUrocortin 1

Identifiers

PMID39266897
PMCPMC11502588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.